Editorial: Disease modifying therapies in multiple sclerosis

Editorial: Disease modifying therapies in multiple sclerosis

Bibliographic Details
Main Authors:	Simona Bonavita, Mahsa Ghajarzadeh, Luigi Lavorgna
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Neurology
Subjects:	multiple sclerosis disease modifying therapy predictors pregnancy pediatric onset multiple sclerosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.927321/full

Similar Items

Multiple sclerosis in a 4-year-old boy: a case report and literature review
by: Ula Arkar, et al.
Published: (2024-03-01)

Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS)
by: Mahsa Ghajarzadeh, et al.
Published: (2022-01-01)

Family Planning Decision Making in People With Multiple Sclerosis
by: Simona Bonavita, et al.
Published: (2021-04-01)

Microbiomes and Pediatric onset multiple sclerosis (MS): A systematic review
by: Sanaz Mehrabani, et al.
Published: (2023-12-01)

Disease Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
by: Negar Molazadeh, et al.
Published: (2023-01-01)

MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis
by: Martin Weygandt, et al.
Published: (2015-01-01)

Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents
by: M. D. Bogdanova, et al.
Published: (2020-08-01)

Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region
by: V. B. Laskov, et al.
Published: (2017-03-01)

Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies
by: Mary Rensel
Published: (2019-05-01)

The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis
by: Naeim Ehtesham, et al.
Published: (2021-06-01)

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study
by: Giuseppina Miele, et al.
Published: (2023-01-01)

Multiple sclerosis in pregnancy. Treatment options and outcomes: a review
by: Delia Cudalba, et al.
Published: (2022-06-01)

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
by: Omid Mirmosayyeb, et al.
Published: (2020-05-01)

Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients
by: Laura Papetti, et al.
Published: (2023-11-01)

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
by: Hamdy SM, et al.
Published: (2018-02-01)

Adherence to disease-modifying therapies in patients with multiple sclerosis
by: Kołtuniuk A, et al.
Published: (2018-08-01)

Pediatric multiple sclerosis
by: Patel Yashma, et al.
Published: (2009-01-01)

Impact of Disease-Modifying Therapies on Gut–Brain Axis in Multiple Sclerosis
by: Ilaria Del Negro, et al.
Published: (2023-12-01)

Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy’s Impact on Disease Activity
by: Guoda Varytė, et al.
Published: (2020-01-01)

Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review
by: Fioravante Capone, et al.
Published: (2022-04-01)

Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics
by: Claudia Mandato, et al.
Published: (2023-06-01)

Pregnancy in multiple sclerosis: from scientific aspects to practical
by: Anna Belenciuc, et al.
Published: (2021-09-01)

Multiple sclerosis /
by: 546326 Dobson, Ruth, et al.
Published: (2013)

Multiple sclerosis : recovery of function and neurorehabilitation /
by: Kesselring, Jurg, et al.
Published: (c201)

Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
by: Melesse DY, et al.
Published: (2017-06-01)

Knowledge domain and trend of disease-modifying therapies for multiple sclerosis: A study based on CiteSpace
by: Ting Zheng, et al.
Published: (2024-03-01)

Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
by: Esther Melamed, et al.
Published: (2020-01-01)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
by: Monica Margoni, et al.
Published: (2021-05-01)

Editorial: Pediatric multiple sclerosis - from bench to bedside
by: Ethel Ciampi, et al.
Published: (2024-04-01)

Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
by: Georges Jalkh, et al.
Published: (2020-12-01)

Mobile Attention Bias Modification Training Is a Digital Health Solution for Managing Distress in Multiple Sclerosis: A Pilot Study in Pediatric Onset
by: Leigh Charvet, et al.
Published: (2021-07-01)

Update on immunopathogenesis and immunotherapy in multiple sclerosis
by: Selter RC, et al.
Published: (2013-04-01)

Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses
by: Yaser M. Al Malik, et al.
Published: (2022-12-01)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
by: Masoud Etemadifar, et al.
Published: (2021-01-01)

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets
by: N. A. Totolyan, et al.
Published: (2020-10-01)

Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
by: Feng J, et al.
Published: (2019-11-01)

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
by: Hamdy SM, et al.
Published: (2020-07-01)

Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
by: Madeline Bross, et al.
Published: (2020-06-01)

Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study
by: Laura Rosa, et al.
Published: (2022-09-01)

Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients
by: Robert A. Brown, et al.
Published: (2014-01-01)